These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39169277)

  • 21. Label-Free Iron Oxide Nanoparticles as Multimodal Contrast Agents in Cells Using Multi-Photon and Magnetic Resonance Imaging.
    Reynders H; Van Zundert I; Silva R; Carlier B; Deschaume O; Bartic C; Rocha S; Basov S; Van Bael MJ; Himmelreich U; Verbiest T; Zamora A
    Int J Nanomedicine; 2021; 16():8375-8389. PubMed ID: 35002233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T
    Zhang H; Li L; Liu XL; Jiao J; Ng CT; Yi JB; Luo YE; Bay BH; Zhao LY; Peng ML; Gu N; Fan HM
    ACS Nano; 2017 Apr; 11(4):3614-3631. PubMed ID: 28371584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications.
    Cotin G; Blanco-Andujar C; Perton F; Asín L; de la Fuente JM; Reichardt W; Schaffner D; Ngyen DV; Mertz D; Kiefer C; Meyer F; Spassov S; Ersen O; Chatzidakis M; Botton GA; Hénoumont C; Laurent S; Greneche JM; Teran FJ; Ortega D; Felder-Flesch D; Begin-Colin S
    Nanoscale; 2021 Sep; 13(34):14552-14571. PubMed ID: 34473175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor.
    Nosrati H; Salehiabar M; Fridoni M; Abdollahifar MA; Kheiri Manjili H; Davaran S; Danafar H
    Sci Rep; 2019 May; 9(1):7173. PubMed ID: 31073222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
    Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
    Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging.
    Casula MF; Corrias A; Arosio P; Lascialfari A; Sen T; Floris P; Bruce IJ
    J Colloid Interface Sci; 2011 May; 357(1):50-5. PubMed ID: 21345440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
    Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
    Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI.
    Girard OM; Ramirez R; McCarty S; Mattrey RF
    Contrast Media Mol Imaging; 2012; 7(4):411-7. PubMed ID: 22649047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of iron oxide nanoparticles as T
    Yang H; Wang H; Wen C; Bai S; Wei P; Xu B; Xu Y; Liang C; Zhang Y; Zhang G; Wen H; Zhang L
    J Nanobiotechnology; 2022 Mar; 20(1):98. PubMed ID: 35236363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
    Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
    Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
    Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
    J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging.
    Hachani R; Birchall MA; Lowdell MW; Kasparis G; Tung LD; Manshian BB; Soenen SJ; Gsell W; Himmelreich U; Gharagouzloo CA; Sridhar S; Thanh NTK
    Sci Rep; 2017 Aug; 7(1):7850. PubMed ID: 28798327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles.
    Tromsdorf UI; Bruns OT; Salmen SC; Beisiegel U; Weller H
    Nano Lett; 2009 Dec; 9(12):4434-40. PubMed ID: 19799448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
    Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
    Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.
    Hachani R; Lowdell M; Birchall M; Hervault A; Mertz D; Begin-Colin S; Thanh NT
    Nanoscale; 2016 Feb; 8(6):3278-87. PubMed ID: 26460932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021).
    Mao Z; Li X; Wang P; Yan H
    Expert Opin Ther Pat; 2022 Sep; 32(9):939-952. PubMed ID: 35929879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward design of magnetic nanoparticle clusters stabilized by biocompatible diblock copolymers for T₂-weighted MRI contrast.
    Balasubramaniam S; Kayandan S; Lin YN; Kelly DF; House MJ; Woodward RC; St Pierre TG; Riffle JS; Davis RM
    Langmuir; 2014 Feb; 30(6):1580-7. PubMed ID: 24479874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular MR Imaging of Prostate Cancer by Specified Iron Oxide Nanoparticles With PSMA-11 Peptides: A Preclinical Study.
    Ghorbani F; Aminzadeh B; Borji N; Soudmand S; Montazerabadi A
    J Magn Reson Imaging; 2024 Jun; 59(6):2204-2214. PubMed ID: 37572082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
    Ahmed N; Ahmad NM; Fessi H; Elaissari A
    Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.